Article
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.
Blood - 3 Feb 2011
Rinaldi Andrea, Mian Michael, Chigrinova Ekaterina, Arcaini Luca, Bhagat Govind, Novak Urban, Rancoita Paola M V, De Campos Cassio P, Forconi Francesco, Gascoyne Randy D, Facchetti Fabio, Ponzoni Maurilio, Govi Silvia, Ferreri Andrés J M, Mollejo Manuela, Piris Miguel A, Baldini Luca, Soulier Jean, Thieblemont Catherine, Canzonieri Vincenzo, Gattei Valter, Marasca Roberto, Franceschetti Silvia, Gaidano Gianluca, Tucci Alessandra, Uccella Silvia, Tibiletti Maria Grazia, Dirnhofer Stephan, Tripodo Claudio, Doglioni Claudio, Dalla Favera Riccardo, Cavalli Franco, Zucca Emanuele, Kwee Ivo, Bertoni Francesco
Abstract excerpt
Marginal zone B-cell lymphomas (MZLs) have been divided into 3 distinct subtypes (extranodal MZLs of mucosa-associated lymphoid tissue [MALT] type, nodal MZLs, and splenic MZLs). Nevertheless, the relationship between the subtypes is still unclear. We performed a comprehensive analysis of genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
